Algeta to Present at Upcoming Investor Conferences

Oslo, Norway, 3 December 2012 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces that members of its senior management team will participate in the following investor conferences: DNB Nordic Healthcare Conference 2012   Date: 6 December 2012   Presenter: Andrew Kay (President & CEO) Presentation time: 10:45am CET   Venue: Oslo, Norway J.P.Morgan Healthcare Conference 2013   Date: 7-10 January 2013   Presenter: Andrew Kay (President & CEO) Presentation date/time: Tuesday 8 January, 2013, 4:00pm PT   Venue: San Francisco, CA, USA The presentations will be available to download at following these events. ### For further information, please contact Mike Booth +47 2202 4510 Communications & Corporate Affairs Media enquiries: Mark Swallow +44 207 638 9571 Citigate Dewe Rogerson Knut Ekern +47 22 04 82 00 Gambit Hill & Knowlton Kari Watson +1 781 235 3060 MacDougall Biomedical Communications US investor enquiries: Tricia Swanson +1 646 378 2953 The Trout Group About Algeta Algeta is a company focused on developing novel targeted therapies for patients with cancer based on its alpha-pharmaceutical platform. The Company is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA performing commercial marketing operations in the US. Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please visit This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Press release: This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Algeta ASA via Thomson Reuters ONE [HUG#1661790]